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Background
Hypertrophic cardiomyopathy (HCM) patients with
massive left ventricular hypertrophy (LVH) (hereby
defined as maximal LV wall thickness >30mm) are
known to have lower rates of survival. Recently, con-
trast-enhanced cardiac magnetic resonance (CMR) with
late gadolinium enhancement (LGE) has emerged as a
potential novel marker of increased cardiovascular risk
in HCM.
Methods
Cine CMR and LGE imaging were performed on HCM
patients with massive LV hypertrophy and compared
with those with a maximal LV wall thickness <30mm.
Results
Among 902 consecutive HCM patients, 40 (4.4%) had a
maximal LV wall thickness of ≥ 30mm (mean thickness
33.7± 4.2mm, range 30 - 50mm, 23% females) with a
mean age of 37 ± 18 years old, including 11 patients
(28%) ≥ 50 years of age. When compared to those with
a maximal wall thickness less than 30mm, these patients
were significantly younger (mean age 37 ± 18 vs 47 ±
18, p<0.001) and had a similar proportion of males
(77.5% versus 66.8%, p=0.16). Mean left ventricular mass
was significantly higher (317 ± 142 versus 163 ± 62
grams, p<0.001). They also had significantly higher LV
end diastolic volume (LVEDV) (169.6 ± 58.5 versus
153.0 ± 42.1 mL, p<0.01) and LV end systolic volume
(LVESV) (63.0± 40.8 versus 49.9 ± 23.1 ml, p=0.001).
They had similar LV ejection fraction (64.8 ± 10.7% ver-
sus 67.6 ± 9.6%, p=0.21), LVEDD (51.7 ± 9.2mm versus
53.1 ± 6.8mm, p=0.21), and stroke volume (106.6 ± 27.5
ml versus 103.1 ± 30.8 ml, p=0.48).
LGE was identified in 95% of HCM patients with mas-
sive LVH, occupying an average of 19.6 g ±19.8 g (or 6.1
± 4.7%) of LV myocardial mass. 18% had LGE occupy-
ing>10% of the LV. In comparison, only 38% of HCM
patients without massive LVH had LGE (p<0.001), occu-
pying an average of only 13.6 ± 17.0 g (or 7.8 ± 9.6%) of
LV myocardial mass (p=0.05).
Univariate associates of massive hypertrophy include
young age (OR=1.37/decade decrease in age, p<0.001 ),
presence of LGE (OR 25.6, p<0.001), amount of LGE
present (OR = 1.31 per 10g increase, p<0.001), presence
of LV dysfunction (defined as LVEF<50%) (OR 3.28,
p=0.01) , LVEDV (OR =1.08 per 10 ml increase in
LVEDV, p=0.018), and LVESV (OR = 1.16 per 10 ml
increase in LVESV, p=0.001). On multivariate regression
analysis, presence of LGE (adjusted OR 21.3, p<0.0001)
and young age (adjusted OR =1.43/decade decrease in
age, p=0.0014) remained significant after controlling for
other factors.
When comparing patients older and young than 30
years old with massive hypertrophy, there were no sig-
nificant differences in LV mass, stroke volume or quan-
tity of LGE (p>0.10). Older patients had a smaller cavity
size (p=0.04) and better cardiac function ( LVEF =67.7
± 9.8% versus 60.8 ± 10.9%, p=0.046).
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Almost all HCM patients with massive LV hypertrophy
demonstrate LGE. These observations may complement
findings demonstrating an increased risk with LGE.
Patients with massive LVH surviving to older age had
better cardiac function and less dilation.
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